Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
118.35
-0.67 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
119.00
0.55%
After-hours: Aug 15, 2025, 07:49 PM EDT

Gilead Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
5.14B 7.93B 9.99B 5.04B 2.77B 4.72B 6.08B 5.71B 5.7B 4.94B 5.41B 4.7B 4.74B 4.3B 5.34B 4.36B 4.89B 4.07B
Short-Term Investments
69M 785M 1.58B 1.66B 1.43B 806M 2.27B 2.27B 963M 936M 973M 961M 924M 1.03B 1.18B 1.38B 1.63B 1.6B
Long-Term Investments
1.91B 684M 327M 730M 710M 1.14B 2.16B 1.74B 1.33B 1.33B 1.25B 1.28B 1.34B 1.43B 1.31B 1.1B 836M 579M
Other Long-Term Assets
4.03B 3.19B 5.82B 4.76B 4.06B 4.04B 3.8B 3.62B 5.11B 4.95B 4.8B 4.62B 4.86B 5.13B 4.96B 4.74B 5.55B 5.53B
Receivables
4.78B 4.39B 4.42B 4.59B 4.66B 4.67B 4.66B 4.79B 4.23B 4.16B 4.78B 4.35B 4.12B 3.79B 4.49B 4.57B 4.15B 3.92B
Inventory
1.82B 1.76B 1.71B 1.87B 2.03B 1.85B 1.79B 1.66B 1.63B 1.58B 1.51B 1.46B 1.49B 1.48B 1.62B 1.68B 1.77B 1.78B
Other Current Assets
2.9B 2.83B 995M 1.63B 1.43B 1.46B 1.29B 1.55B 1.76B 1.85B n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
14.72B 16.9B 19.17B 14.78B 12.32B 14.04B 16.09B 15.98B 14.29B 13.46B 14.44B 13.55B 13.18B 12.63B 14.77B 13.99B 13.93B 13.28B
Property-Plant & Equipment
5.46B 5.42B 5.41B 5.39B 5.35B 5.32B 5.32B 5.57B 5.54B 5.48B 5.47B 5.35B 5.3B 5.25B 5.12B 5.04B 5B 4.99B
Goodwill & Intangibles
26.88B 27.67B 28.26B 28.86B 31.15B 31.74B 34.77B 35.47B 36.06B 36.66B 37.21B 37.75B 38.2B 38.64B 41.79B 42.23B 42.67B 43.12B
Total Long-Term Assets
41.01B 39.53B 39.82B 39.74B 41.26B 42.25B 46.04B 46.39B 48.05B 48.42B 48.73B 49B 49.69B 50.45B 53.18B 53.11B 54.06B 54.21B
Total Assets
55.72B 56.43B 58.99B 54.52B 53.58B 56.29B 62.13B 62.37B 62.34B 61.88B 63.17B 62.56B 62.87B 63.08B 67.95B 67.1B 67.98B 67.49B
Account Payables
582M 737M 833M 903M 537M 622M 550M 586M 622M 627M 905M 614M 565M 583M 705M 585M 608M 570M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
2.81B 2.81B 1.81B 1.81B 1.81B 3.67B 1.8B 1.79B 4.04B 2.28B 2.27B 2.27B 1.02B 1.02B 1.52B 2.51B 2.26B 2.26B
Other Current Liabilities
3.59B 4.62B 3.71B 3.36B 3.25B 3.27B 3.8B 3.77B 3.58B 1.15B 3.62B 1.14B 1B 962M 1.43B 1.22B 1.12B 1.02B
Total Current Liabilities
11.19B 12.34B 12B 11.72B 10.78B 13.02B 11.28B 11.95B 13.96B 10.53B 11.24B 10.42B 9.22B 8.56B 11.61B 10.24B 10.21B 9.71B
Long-Term Debt
22.14B 22.15B 24.9B 21.44B 21.54B 21.53B 23.19B 23.19B 21.21B 22.96B 22.96B 22.95B 25.2B 25.18B 25.18B 25.18B 27.91B 27.91B
Other Long-Term Liabilities
2.15B 2.16B 1.63B 2.18B 2.15B 3.36B 2.77B 3.01B 3.96B 5.05B 5.09B 5.09B 4.88B 5.74B 5.74B 5.6B 5.77B 6.45B
Total Long-Term Liabilities
24.94B 25.01B 27.75B 24.41B 24.6B 25.82B 28.1B 28.19B 27.28B 30.41B 30.72B 31.08B 33.44B 34.61B 35.28B 35.38B 38.06B 38.82B
Total Liabilities
36.13B 37.36B 39.75B 36.13B 35.38B 38.84B 39.38B 40.13B 41.24B 40.94B 41.96B 41.5B 42.66B 43.16B 46.89B 45.63B 48.27B 48.53B
Total Debt
24.95B 24.95B 27.32B 23.25B 23.35B 25.19B 25.66B 24.98B 25.25B 25.24B 25.23B 25.22B 26.22B 26.21B 26.7B 27.69B 30.18B 30.17B
Common Stock
1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
Retained Earnings
11.32B 10.93B 11.5B 11.07B 11.16B 10.66B 16.3B 16B 15.14B 15.22B 15.69B 15.76B 15.12B 14.99B 16.32B 16.9B 15.39B 14.82B
Comprehensive Income
-18M 92M 132M 73M 93M 69M 28M 31M 10M -20M 2M 98M 87M 73M 83M 74M 39M 38M
Shareholders Equity
19.68B 19.16B 19.33B 18.47B 18.28B 17.54B 22.83B 22.31B 21.16B 21B 21.24B 21.08B 20.24B 19.93B 21.07B 21.47B 19.7B 18.95B
Total Investments
1.98B 1.47B 1.58B 2.39B 2.14B 1.95B 4.42B 4.01B 2.3B 2.26B 2.22B 2.24B 2.26B 2.46B 2.49B 2.48B 2.47B 2.18B